Transient opening of the perineurial barrier for analgesic drug delivery

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2012-06-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/pnas.1120800109PMID 22733753PMCID PMC3406837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• μ-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve

  2011cited by this paper
• Prolonged sensory-selective nerve blockade

  2010cited by this paper
• The tetrodotoxin-resistant Na+ channel Nav1.8 reduces the potency of local anesthetics in blocking C-fiber nociceptors

  2010cited by this paper
• TNFα-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFκB signaling

  2010cited by this paper
• Segmental expression of claudin proteins correlates with tight junction barrier properties in rat intestine

  2010cited by this paper
• Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions

  2010cited by this paper
• Neisseria meningitidis Induces Brain Microvascular Endothelial Cell Detachment from the Matrix and Cleavage of Occludin: A Role for MMP-8

  2010cited by this paper
• Immune cell-derived opioids protect against neuropathic pain in mice.

  2009cited by this paper
• Mycobacteria Attenuate Nociceptive Responses by Formyl Peptide Receptor Triggered Opioid Peptide Release from Neutrophils

  2009cited by this paper
• Two-path impedance spectroscopy for measuring paracellular and transcellular epithelial resistance.

  2009cited by this paper
• Antinociception by neutrophil-derived opioid peptides in noninflamed tissue--role of hypertonicity and the perineurium.

  2009cited by this paper
• Role of TTX-sensitive and TTX-resistant sodium channels in Adelta- and C-fiber conduction and synaptic transmission.

  2008cited by this paper
• The Hemopexin Domain of Matrix Metalloproteinase-9 Activates Cell Signaling and Promotes Migration of Schwann Cells by Binding to Low-Density Lipoprotein Receptor-Related Protein

  2008influential reference
• Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier.

  2008cited by this paper
• ProTx-II, a Selective Inhibitor of NaV1.7 Sodium Channels, Blocks Action Potential Propagation in Nociceptors

  2008cited by this paper
• The normal and neoplastic perineurium: a review.

  2008cited by this paper
• Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain.

  2007cited by this paper
• Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures

  2007cited by this paper
• Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers

  2007cited by this paper
• Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in Rat

  2007cited by this paper
• Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit.

  2007cited by this paper
• Hypertonic saline enhances neutrophil elastase release through activation of P2 and A3 receptors.

  2006cited by this paper
• Hyperosmolar Saline Is a Proinflammatory Stress on the Mouse Ocular Surface

  2005cited by this paper
• Mobilization of Opioid-containing Polymorphonuclear Cells by Hematopoietic Growth Factors and Influence on Inflammatory Pain

  2004cited by this paper
• Tight Junction Proteins ZO-1, Occludin, and Claudins in Developing and Adult Human Perineurium

  2004cited by this paper
• Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid‐containing leukocytes but by opioid receptor expression

  2004cited by this paper
• Immunogold localization of tight junctional proteins in normal and osmotically-affected rat blood-brain barrier

  2004cited by this paper
• Rapid upregulation of μ opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction

  2004cited by this paper
• Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.

  2004cited by this paper
• Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration.

  2004cited by this paper
• μ Opioid receptors and analgesia at the site of a peripheral nerve injury

  2003cited by this paper
• Loss and recovery of the blood-nerve barrier in the rat sciatic nerve after crush injury are associated with expression of intercellular junctional proteins.

  2003cited by this paper
• Attacking pain at its source: new perspectives on opioids

  2003cited by this paper
• Immunogold localization of tight junctional proteins in normal and osmotically-affected rat blood-brain barrier

  2003cited by this paper
• Mu opioid receptors and analgesia at the site of a peripheral nerve injury.

  2003cited by this paper
• The Matrix Metalloproteinase 9 (MMP-9) Hemopexin Domain Is a Novel Gelatin Binding Domain and Acts as an Antagonist*

  2002cited by this paper
• Claudin-based tight junctions are crucial for the mammalian epidermal barrier

  2002cited by this paper
• Perineural antinociceptive effect of opioids in a rat model

  2001cited by this paper
• Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression.

  2001cited by this paper
• Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications

  2000cited by this paper
• Rat peripheral nerve components release calcitonin gene-related peptide and prostaglandin E2 in response to noxious stimuli: evidence that nervi nervorum are nociceptors.

  1999cited by this paper
• Analgesic efficacy of peripheral opioids (all except intra‐articular): a qualitative systematic review of randomised controlled trials

  1997cited by this paper
• Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.

  1997cited by this paper
• Perineurial defect and peripheral opioid analgesia in inflammation

  1995cited by this paper
• Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation.

  1990influential reference
• Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.

  1989cited by this paper

• Modulation of antibody transport in the brain and spinal cord through the intranasal pathway

  2025cites this paper
• The role and mechanisms of matrix metalloproteinase-9 in peripheral neuropathic pain

  2025cites this paper
• Bilateral deficiency of Meissner corpuscles and papillary microvessels in patients with acute complex regional pain syndrome

  2024cites this paper
• TAM receptors mediate the Fpr2-driven pain resolution and fibrinolysis after nerve injury

  2024cites this paper
• Therapeutic Implication of miRNAs as an Active Regulatory Player in the Management of Pain: A Review

  2024cites this paper
• Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system.

  2024cites this paper
• Myelin barrier breakdown, mechanical hypersensitivity, and painfulness in polyneuropathy with claudin-12 deficiency.

  2023influential citation
• Primary perineuritis, a rare but treatable neuropathy: Review of perineurial anatomy, clinicopathological features, and differential diagnosis

  2023cites this paper
• Drug Permeability: From the Blood–Brain Barrier to the Peripheral Nerve Barriers

  2023cites this paper
• Stabilizing the neural barrier - A novel approach in pain therapy.

  2023cites this paper
• MicroRNA‐21‐5p functions via RECK/MMP9 as a proalgesic regulator of the blood nerve barrier in nerve injury

  2022cites this paper
• Structure and barrier functions of the perineurium and its relationship with associated sensory corpuscles: A review.

  2022cites this paper
• Netrin-1 as a Multitarget Barrier Stabilizer in the Peripheral Nerve after Injury

  2021cites this paper
• Selective Targeting of Nav1.7 with Engineered Spider Venom-Based Peptides

  2021cites this paper
• FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review

  2021cites this paper
• Selective blood-nerve barrier leakiness with claudin-1 and vessel-associated macrophage loss in diabetic polyneuropathy

  2021cites this paper
• Morphine Suppresses Liver Cancer Cell Tumor Properties In Vitro and In Vivo

  2021cites this paper
• Liposomal Bupivacaine (Bupigel) Demonstrates Minimal Local Nerve Toxicity in a Rabbit Functional Model

  2021cites this paper
• Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Nav1.7 for the Treatment of Pain.

  2021cites this paper
• Stabilization of Delphinidin in Complex with Sulfobutylether-β-Cyclodextrin Allows for Antinociception in Inflammatory Pain

  2020cites this paper
• Characteristics of the nerve barrier and the blood dorsal root ganglion barrier in health and disease.

  2020cites this paper
• Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.

  2020cites this paper
• Immune cell-mediated opioid analgesia.

  2020cites this paper
• Fifteen years of NaV1.7 channels as an analgesic target: Why has excellent in vitro pharmacology not translated into in vivo analgesic efficacy?

  2020cites this paper
• Claudin-12 deficiency causes nerve barrier breakdown, mechanical hypersensitivity and painfulness in polyneuropathy

  2019cites this paper
• Engineering NaV1.7 Inhibitory JzTx-V Peptides with a Potency and Basicity Profile Suitable for Antibody Conjugation To Enhance Pharmacokinetics.

  2019cites this paper
• Anti-allodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute post-surgical pain: evidence for analgesic synergy with opioids and baclofen.

  2019cites this paper
• Intracerebroventricular Coadministration of Protoxin-II and Trace Elements in Rats Enhances the Analgesic Effect of the 1.7 Voltage-Gate Sodium Channel Blocker

  2019cites this paper
• Macrophages Enforce the Blood Nerve Barrier

  2019cites this paper
• Regional Differences in Tight Junction Protein Expression in the Blood–DRG Barrier and Their Alterations after Nerve Traumatic Injury in Rats

  2019cites this paper
• Multipotent vascular stem cells contribute to neurovascular regeneration of peripheral nerve

  2019cites this paper
• Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy

  2019cites this paper
• Antinociception by the anti‐oxidized phospholipid antibody E06

  2018cites this paper
• Hollow Silica Nanoparticles Penetrate the Peripheral Nerve and Enhance the Nerve Blockade from Tetrodotoxin.

  2018cites this paper
• Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7.

  2018cites this paper
• Toxins as tools: Fingerprinting neuronal pharmacology.

  2018cites this paper
• High‐frequency, low‐intensity ultrasound and microbubbles enhance nerve blockade

  2018cites this paper
• Zinc ions regulate opening of tight junction favouring efflux of macromolecules via the GSK3β/snail-mediated pathway.

  2018cites this paper
• Trauma-Induced Heterotopic Ossification Regulates the Blood-Nerve Barrier

  2018cites this paper
• Astroglial Modulation of Hydromineral Balance and Cerebral Edema

  2018cites this paper
• Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose‐response, and mechanisms of delivery

  2018cites this paper
• The NaV1.7 Channel Subtype as an Antinociceptive Target for Spider Toxins in Adult Dorsal Root Ganglia Neurons

  2018cites this paper
• Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain.

  2018cites this paper
• Recent progress in non-opioid analgesic peptides.

  2018cites this paper
• Peripheral Nerve Injury Induces Dynamic Changes of Tight Junction Components

  2018cites this paper
• Strategies for Targeted Delivery to the Peripheral Nerve

  2018cites this paper
• Advances in Achieving Opioid Analgesia Without Side Effects

  2018cites this paper
• Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats

  2017cites this paper
• Is heterotopic ossification getting nervous?: The role of the peripheral nervous system in heterotopic ossification.

  2017cites this paper
• Sodium Channel Nav1.8 Underlies TTX-Resistant Axonal Action Potential Conduction in Somatosensory C-Fibers of Distal Cutaneous Nerves

  2017cites this paper
• Intranasal delivery of N‐terminal modified leptin‐pluronic conjugate for treatment of obesity

  2017cites this paper
• Blood–spinal cord barrier breakdown and pericyte deficiency in peripheral neuropathy

  2017cites this paper
• The NAv1.7 blocker protoxin II reduces burn injury-induced spinal nociceptive processing

  2017cites this paper
• Ciguatoxins Evoke Potent CGRP Release by Activation of Voltage-Gated Sodium Channel Subtypes NaV1.9, NaV1.7 and NaV1.1

  2017cites this paper
• Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor

  2017cites this paper
• Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation

  2017cites this paper
• Progress and challenges in the optimization of toxin peptides for development as pain therapeutics.

  2017cites this paper
• A Novel Approach for the Control of Inflammatory Pain: Prostaglandin E2 Complexation by Randomly Methylated &bgr;-Cyclodextrins

  2017cites this paper
• Getting Drugs Across Biological Barriers

  2017cites this paper
• The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception.

  2016cites this paper
• Location‐dependent heterotopic ossification in the rat model: The role of activated matrix metalloproteinase 9

  2016influential citation
• Analgesic drug delivery via recombinant tissue plasminogen activator and microRNA-183-triggered opening of the blood-nerve barrier.

  2016cites this paper
• Functional and structural characterization of axonal opioid receptors as targets for analgesia

  2016influential citation
• Claudin expression in follicle‐associated epithelium of rat Peyer's patches defines a major restriction of the paracellular pathway

  2016cites this paper
• Future of Critical Care Medicine

  2016cites this paper
• Rapid Transport within Cerebral Perivascular Spaces Underlies Widespread Tracer Distribution in the Brain after Intranasal Administration

  2015cites this paper
• Pain Modulating Peptides in Spider Venoms: Good and Evil

  2015cites this paper
• Opioid receptors as therapeutic targets for nociceptor specific regional analgesia Opioidrezeptoren als therapeutisches Target einer nozizeptionsspezifischen Regionalanalgesie

  2015cites this paper
• Antihyperalgesic effect of tetrodotoxin in rat models of persistent muscle pain.

  2015cites this paper
• Redox-Sensitive Structure and Function of the First Extracellular Loop of the Cell–Cell Contact Protein Claudin-1: Lessons from Molecular Structure to Animals

  2015cites this paper
• Abnormal junctions and permeability of myelin in PMP22‐deficient nerves

  2014cites this paper
• Blood‐nerve barrier dysfunction contributes to the generation of neuropathic pain and allows targeting of injured nerves for pain relief

  2014cites this paper
• Differential expression of the alternatively spliced OPRM1 isoform &mgr;-opioid receptor-1K in HIV-infected individuals

  2014cites this paper
• Drug Delivery to the Brain

  2014cites this paper
• [The new era of epithelium-targeted drug development].

  2014cites this paper
• Anatomy and Physiology of the Blood–Brain Barriers

  2014cites this paper
• Update zu Pharmakologie und Wirkung von Lokalanästhetika

  2014cites this paper
• Opioids for the treatment of arthritis pain

  2014cites this paper
• Safety, efficacy, and molecular mechanism of claudin-1-specific peptides to enhance blood-nerve-barrier permeability.

  2014cites this paper
• The role of the blood–brain barrier in the development and treatment of migraine and other pain disorders

  2014cites this paper
• Opioid withdrawal increases transient receptor potential vanilloid 1 activity in a protein kinase A‐dependent manner

  2013cites this paper
• Endogenous opiates and behavior: 2012.

  2013cites this paper
• Barriers of the peripheral nerve

  2013cites this paper
• Trends in drug delivery through tissue barriers containing tight junctions

  2013cites this paper
• Obstetric and Gynecological Pain

  2013cites this paper
• Recent advances in claudin-targeting technology.

  2013cites this paper
• Beweglich bleiben trotz Regionalanästhesie – Nachgehakt bei PD Dr. med. Heike Rittner

  2012cites this paper